Clovis drug to be reviewed by European agency

The European Medicines Agency will review an application by Boulder's Clovis Oncology that requests approval for expanded use of the drug Rubraca, according to a company news release.

Clovis drug to be reviewed by European agency
QR Code
Embed the QR code on your website:
Download
Copy